179 related articles for article (PubMed ID: 36582458)
21. Identification of FES as a Novel Radiosensitizing Target in Human Cancers.
Kim BH; Kim YJ; Kim MH; Na YR; Jung D; Seok SH; Kim J; Kim HJ
Clin Cancer Res; 2020 Jan; 26(1):265-273. PubMed ID: 31573955
[TBL] [Abstract][Full Text] [Related]
22. Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo.
Hofstetter B; Vuong V; Broggini-Tenzer A; Bodis S; Ciernik IF; Fabbro D; Wartmann M; Folkers G; Pruschy M
Clin Cancer Res; 2005 Feb; 11(4):1588-96. PubMed ID: 15746064
[TBL] [Abstract][Full Text] [Related]
23. AGuIX nanoparticles enhance ionizing radiation-induced ferroptosis on tumor cells by targeting the NRF2-GPX4 signaling pathway.
Sun H; Cai H; Xu C; Zhai H; Lux F; Xie Y; Feng L; Du L; Liu Y; Sun X; Wang Q; Song H; He N; Zhang M; Ji K; Wang J; Gu Y; Leduc G; Doussineau T; Wang Y; Liu Q; Tillement O
J Nanobiotechnology; 2022 Oct; 20(1):449. PubMed ID: 36242003
[TBL] [Abstract][Full Text] [Related]
24. Gadolinium Oxide Nanoparticles Reinforce the Fractionated Radiotherapy-Induced Immune Response in Tri-Negative Breast Cancer via cGAS-STING Pathway.
Yu B; Lu X; Feng X; Zhao T; Li J; Lu Y; Ye F; Liu X; Zheng X; Shen Z; Jin X; Chen W; Li Q
Int J Nanomedicine; 2023; 18():7713-7728. PubMed ID: 38115988
[TBL] [Abstract][Full Text] [Related]
25. Multifunction bismuth gadolinium oxide nanoparticles as radiosensitizer in radiation therapy and imaging.
Rajaee A; Wang S; Zhao L; Wang D; Liu Y; Wang J; Ying K
Phys Med Biol; 2019 Oct; 64(19):195007. PubMed ID: 31082811
[TBL] [Abstract][Full Text] [Related]
26. An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing.
van Oosterwijk JG; Plass JR; Meijer D; Que I; Karperien M; Bovée JV
Virchows Arch; 2015 Jan; 466(1):101-9. PubMed ID: 25331842
[TBL] [Abstract][Full Text] [Related]
27. In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells.
Mowat P; Mignot A; Rima W; Lux F; Tillement O; Roulin C; Dutreix M; Bechet D; Huger S; Humbert L; Barberi-Heyob M; Aloy MT; Armandy E; Rodriguez-Lafrasse C; Le Duc G; Roux S; Perriat P
J Nanosci Nanotechnol; 2011 Sep; 11(9):7833-9. PubMed ID: 22097494
[TBL] [Abstract][Full Text] [Related]
28. Administration of salubrinal enhances radiation-induced cell death of SW1353 chondrosarcoma cells.
Koizumi M; Tanjung NG; Chen A; Dynlacht JR; Garrett J; Yoshioka Y; Ogawa K; Teshima T; Yokota H
Anticancer Res; 2012 Sep; 32(9):3667-73. PubMed ID: 22993304
[TBL] [Abstract][Full Text] [Related]
29. COX-2 expression in chondrosarcoma: a role for celecoxib treatment?
Schrage YM; Machado I; Meijer D; Briaire-de Bruijn I; van den Akker BE; Taminiau AH; Kalinski T; Llombart-Bosch A; Bovée JV
Eur J Cancer; 2010 Feb; 46(3):616-24. PubMed ID: 20004565
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of radiosensitizing doped titania nanoparticles under hypoxia and preparation of an embolic microparticle.
Morrison RA; Rybak-Smith MJ; Thompson JM; Thiebaut B; Hill MA; Townley HE
Int J Nanomedicine; 2017; 12():3851-3863. PubMed ID: 28572729
[TBL] [Abstract][Full Text] [Related]
31. Iron-oxide nanoparticles target intracellular HSP90 to induce tumor radio-sensitization.
Shetake NG; Kumar A; Pandey BN
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):857-869. PubMed ID: 30794824
[TBL] [Abstract][Full Text] [Related]
32. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
[TBL] [Abstract][Full Text] [Related]
33. AGuIX
Lux F; Tran VL; Thomas E; Dufort S; Rossetti F; Martini M; Truillet C; Doussineau T; Bort G; Denat F; Boschetti F; Angelovski G; Detappe A; Crémillieux Y; Mignet N; Doan BT; Larrat B; Meriaux S; Barbier E; Roux S; Fries P; Müller A; Abadjian MC; Anderson C; Canet-Soulas E; Bouziotis P; Barberi-Heyob M; Frochot C; Verry C; Balosso J; Evans M; Sidi-Boumedine J; Janier M; Butterworth K; McMahon S; Prise K; Aloy MT; Ardail D; Rodriguez-Lafrasse C; Porcel E; Lacombe S; Berbeco R; Allouch A; Perfettini JL; Chargari C; Deutsch E; Le Duc G; Tillement O
Br J Radiol; 2019 Jan; 92(1093):20180365. PubMed ID: 30226413
[TBL] [Abstract][Full Text] [Related]
34. Gadolinium-based nanoparticles as sensitizing agents to carbon ions in head and neck tumor cells.
Wozny AS; Aloy MT; Alphonse G; Magné N; Janier M; Tillement O; Lux F; Beuve M; Rodriguez-Lafrasse C
Nanomedicine; 2017 Nov; 13(8):2655-2660. PubMed ID: 28779947
[TBL] [Abstract][Full Text] [Related]
35. The in vivo radiosensitizing effect of gold nanoparticles based MRI contrast agents.
Miladi I; Alric C; Dufort S; Mowat P; Dutour A; Mandon C; Laurent G; Bräuer-Krisch E; Herath N; Coll JL; Dutreix M; Lux F; Bazzi R; Billotey C; Janier M; Perriat P; Le Duc G; Roux S; Tillement O
Small; 2014 Mar; 10(6):1116-24. PubMed ID: 24659273
[TBL] [Abstract][Full Text] [Related]
36. Gadolinium-Based Nanoparticles and Radiation Therapy for Multiple Brain Melanoma Metastases: Proof of Concept before Phase I Trial.
Kotb S; Detappe A; Lux F; Appaix F; Barbier EL; Tran VL; Plissonneau M; Gehan H; Lefranc F; Rodriguez-Lafrasse C; Verry C; Berbeco R; Tillement O; Sancey L
Theranostics; 2016; 6(3):418-27. PubMed ID: 26909115
[TBL] [Abstract][Full Text] [Related]
37. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
Dwarakanath BS; Adhikari JS; Jain V
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
[TBL] [Abstract][Full Text] [Related]
38. [Use of nanoparticles as radiosensitizing agents in radiotherapy: State of play].
Verry C; Porcel E; Chargari C; Rodriguez-Lafrasse C; Balosso J
Cancer Radiother; 2019 Dec; 23(8):917-921. PubMed ID: 31540838
[TBL] [Abstract][Full Text] [Related]
39. Intrinsic radiation resistance in human chondrosarcoma cells.
Moussavi-Harami F; Mollano A; Martin JA; Ayoob A; Domann FE; Gitelis S; Buckwalter JA
Biochem Biophys Res Commun; 2006 Jul; 346(2):379-85. PubMed ID: 16765318
[TBL] [Abstract][Full Text] [Related]
40. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
Narayan RS; Gasol A; Slangen PLG; Cornelissen FMG; Lagerweij T; Veldman HYYE; Dik R; van den Berg J; Slotman BJ; Würdinger T; Haas-Kogan DA; Stalpers LJA; Baumert BG; Westerman BA; Theys J; Sminia P
Mol Cancer Ther; 2018 Feb; 17(2):347-354. PubMed ID: 28958992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
